PER 0.00% 10.0¢ percheron therapeutics limited

Sammy boy - geesh is that a pump :D Agree, ANP has a good...

  1. 4,694 Posts.
    lightbulb Created with Sketch. 1089
    Sammy boy - geesh is that a pump

    Agree, ANP has a good problem on its hands - the P2 data is awesome - that's what matters most.

    Sarepta's rise from $60m to $1B was very swift - are we going to see that here?

    Sarepta has been the guide post from day one - Moses and Diamond continue to point to them as being the nearest comparison in terms of peer performance.

    At $50m market cap - it is surreal to think we are one trial away - Fast Track designation-from a FDA application into a $6B market.

    Won't be long before the move starts.

    Keep smiling Sammy.
    Last edited by Uboy: 09/10/20
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.